Deep Learning for the Classification of Small-Cell and Non-Small-Cell Lung Cancer

Reliable entity subtyping is paramount for therapy stratification in lung cancer. Morphological evaluation remains the basis for entity subtyping and directs the application of additional methods such as immunohistochemistry (IHC). The decision of whether to perform IHC for subtyping is subjective,...

Full description

Bibliographic Details
Main Authors: Mark Kriegsmann, Christian Haag, Cleo-Aron Weis, Georg Steinbuss, Arne Warth, Christiane Zgorzelski, Thomas Muley, Hauke Winter, Martin E. Eichhorn, Florian Eichhorn, Joerg Kriegsmann, Petros Christopolous, Michael Thomas, Mathias Witzens-Harig, Peter Sinn, Moritz von Winterfeld, Claus Peter Heussel, Felix J. F. Herth, Frederick Klauschen, Albrecht Stenzinger, Katharina Kriegsmann
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/6/1604
id doaj-d77f75e060c541c98e178178e8b928c4
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Mark Kriegsmann
Christian Haag
Cleo-Aron Weis
Georg Steinbuss
Arne Warth
Christiane Zgorzelski
Thomas Muley
Hauke Winter
Martin E. Eichhorn
Florian Eichhorn
Joerg Kriegsmann
Petros Christopolous
Michael Thomas
Mathias Witzens-Harig
Peter Sinn
Moritz von Winterfeld
Claus Peter Heussel
Felix J. F. Herth
Frederick Klauschen
Albrecht Stenzinger
Katharina Kriegsmann
spellingShingle Mark Kriegsmann
Christian Haag
Cleo-Aron Weis
Georg Steinbuss
Arne Warth
Christiane Zgorzelski
Thomas Muley
Hauke Winter
Martin E. Eichhorn
Florian Eichhorn
Joerg Kriegsmann
Petros Christopolous
Michael Thomas
Mathias Witzens-Harig
Peter Sinn
Moritz von Winterfeld
Claus Peter Heussel
Felix J. F. Herth
Frederick Klauschen
Albrecht Stenzinger
Katharina Kriegsmann
Deep Learning for the Classification of Small-Cell and Non-Small-Cell Lung Cancer
Cancers
Artificial intelligence
deep learning
lung cancer
histology
non-small cell lung cancer
small cell lung cancer
author_facet Mark Kriegsmann
Christian Haag
Cleo-Aron Weis
Georg Steinbuss
Arne Warth
Christiane Zgorzelski
Thomas Muley
Hauke Winter
Martin E. Eichhorn
Florian Eichhorn
Joerg Kriegsmann
Petros Christopolous
Michael Thomas
Mathias Witzens-Harig
Peter Sinn
Moritz von Winterfeld
Claus Peter Heussel
Felix J. F. Herth
Frederick Klauschen
Albrecht Stenzinger
Katharina Kriegsmann
author_sort Mark Kriegsmann
title Deep Learning for the Classification of Small-Cell and Non-Small-Cell Lung Cancer
title_short Deep Learning for the Classification of Small-Cell and Non-Small-Cell Lung Cancer
title_full Deep Learning for the Classification of Small-Cell and Non-Small-Cell Lung Cancer
title_fullStr Deep Learning for the Classification of Small-Cell and Non-Small-Cell Lung Cancer
title_full_unstemmed Deep Learning for the Classification of Small-Cell and Non-Small-Cell Lung Cancer
title_sort deep learning for the classification of small-cell and non-small-cell lung cancer
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2020-06-01
description Reliable entity subtyping is paramount for therapy stratification in lung cancer. Morphological evaluation remains the basis for entity subtyping and directs the application of additional methods such as immunohistochemistry (IHC). The decision of whether to perform IHC for subtyping is subjective, and access to IHC is not available worldwide. Thus, the application of additional methods to support morphological entity subtyping is desirable. Therefore, the ability of convolutional neuronal networks (CNNs) to classify the most common lung cancer subtypes, pulmonary adenocarcinoma (ADC), pulmonary squamous cell carcinoma (SqCC), and small-cell lung cancer (SCLC), was evaluated. A cohort of 80 ADC, 80 SqCC, 80 SCLC, and 30 skeletal muscle specimens was assembled; slides were scanned; tumor areas were annotated; image patches were extracted; and cases were randomly assigned to a training, validation or test set. Multiple CNN architectures (VGG16, InceptionV3, and InceptionResNetV2) were trained and optimized to classify the four entities. A quality control (QC) metric was established. An optimized InceptionV3 CNN architecture yielded the highest classification accuracy and was used for the classification of the test set. Image patch and patient-based CNN classification results were 95% and 100% in the test set after the application of strict QC. Misclassified cases mainly included ADC and SqCC. The QC metric identified cases that needed further IHC for definite entity subtyping. The study highlights the potential and limitations of CNN image classification models for tumor differentiation.
topic Artificial intelligence
deep learning
lung cancer
histology
non-small cell lung cancer
small cell lung cancer
url https://www.mdpi.com/2072-6694/12/6/1604
work_keys_str_mv AT markkriegsmann deeplearningfortheclassificationofsmallcellandnonsmallcelllungcancer
AT christianhaag deeplearningfortheclassificationofsmallcellandnonsmallcelllungcancer
AT cleoaronweis deeplearningfortheclassificationofsmallcellandnonsmallcelllungcancer
AT georgsteinbuss deeplearningfortheclassificationofsmallcellandnonsmallcelllungcancer
AT arnewarth deeplearningfortheclassificationofsmallcellandnonsmallcelllungcancer
AT christianezgorzelski deeplearningfortheclassificationofsmallcellandnonsmallcelllungcancer
AT thomasmuley deeplearningfortheclassificationofsmallcellandnonsmallcelllungcancer
AT haukewinter deeplearningfortheclassificationofsmallcellandnonsmallcelllungcancer
AT martineeichhorn deeplearningfortheclassificationofsmallcellandnonsmallcelllungcancer
AT florianeichhorn deeplearningfortheclassificationofsmallcellandnonsmallcelllungcancer
AT joergkriegsmann deeplearningfortheclassificationofsmallcellandnonsmallcelllungcancer
AT petroschristopolous deeplearningfortheclassificationofsmallcellandnonsmallcelllungcancer
AT michaelthomas deeplearningfortheclassificationofsmallcellandnonsmallcelllungcancer
AT mathiaswitzensharig deeplearningfortheclassificationofsmallcellandnonsmallcelllungcancer
AT petersinn deeplearningfortheclassificationofsmallcellandnonsmallcelllungcancer
AT moritzvonwinterfeld deeplearningfortheclassificationofsmallcellandnonsmallcelllungcancer
AT clauspeterheussel deeplearningfortheclassificationofsmallcellandnonsmallcelllungcancer
AT felixjfherth deeplearningfortheclassificationofsmallcellandnonsmallcelllungcancer
AT frederickklauschen deeplearningfortheclassificationofsmallcellandnonsmallcelllungcancer
AT albrechtstenzinger deeplearningfortheclassificationofsmallcellandnonsmallcelllungcancer
AT katharinakriegsmann deeplearningfortheclassificationofsmallcellandnonsmallcelllungcancer
_version_ 1724730536940797952
spelling doaj-d77f75e060c541c98e178178e8b928c42020-11-25T02:52:21ZengMDPI AGCancers2072-66942020-06-01121604160410.3390/cancers12061604Deep Learning for the Classification of Small-Cell and Non-Small-Cell Lung CancerMark Kriegsmann0Christian Haag1Cleo-Aron Weis2Georg Steinbuss3Arne Warth4Christiane Zgorzelski5Thomas Muley6Hauke Winter7Martin E. Eichhorn8Florian Eichhorn9Joerg Kriegsmann10Petros Christopolous11Michael Thomas12Mathias Witzens-Harig13Peter Sinn14Moritz von Winterfeld15Claus Peter Heussel16Felix J. F. Herth17Frederick Klauschen18Albrecht Stenzinger19Katharina Kriegsmann20Institute of Pathology, Heidelberg University, 69120 Heidelberg, GermanyInstitute of Pathology, Heidelberg University, 69120 Heidelberg, GermanyInstitute of Pathology, University Medical Centre Mannheim, Heidelberg University, 68782 Mannheim, GermanyInstitute of Pathology, Heidelberg University, 69120 Heidelberg, GermanyInstitute of Pathology, Cytopathology, and Molecular Pathology, UEGP MVZ Gießen/Wetzlar/LimburgInstitute of Pathology, Heidelberg University, 69120 Heidelberg, GermanyTranslational Lung Research Centre Heidelberg, Member of the German Centre for Lung Research (DZL), 69120 Heidelberg, GermanyTranslational Lung Research Centre Heidelberg, Member of the German Centre for Lung Research (DZL), 69120 Heidelberg, GermanyTranslational Lung Research Centre Heidelberg, Member of the German Centre for Lung Research (DZL), 69120 Heidelberg, GermanyTranslational Lung Research Centre Heidelberg, Member of the German Centre for Lung Research (DZL), 69120 Heidelberg, GermanyMolecular Pathology Trier, 54296 Trier, GermanyTranslational Lung Research Centre Heidelberg, Member of the German Centre for Lung Research (DZL), 69120 Heidelberg, GermanyTranslational Lung Research Centre Heidelberg, Member of the German Centre for Lung Research (DZL), 69120 Heidelberg, GermanyMedical Faculty Heidelberg University, 69120 Heidelberg, GermanyInstitute of Pathology, Heidelberg University, 69120 Heidelberg, GermanyInstitute of Pathology, Heidelberg University, 69120 Heidelberg, GermanyTranslational Lung Research Centre Heidelberg, Member of the German Centre for Lung Research (DZL), 69120 Heidelberg, GermanyTranslational Lung Research Centre Heidelberg, Member of the German Centre for Lung Research (DZL), 69120 Heidelberg, GermanyInstitute of Pathology, University Hospital Charité, 10117 Berlin, GermanyInstitute of Pathology, Heidelberg University, 69120 Heidelberg, GermanyDepartment Hematology, Oncology and Rheumatology, Heidelberg University, 69120 Heidelberg, GermanyReliable entity subtyping is paramount for therapy stratification in lung cancer. Morphological evaluation remains the basis for entity subtyping and directs the application of additional methods such as immunohistochemistry (IHC). The decision of whether to perform IHC for subtyping is subjective, and access to IHC is not available worldwide. Thus, the application of additional methods to support morphological entity subtyping is desirable. Therefore, the ability of convolutional neuronal networks (CNNs) to classify the most common lung cancer subtypes, pulmonary adenocarcinoma (ADC), pulmonary squamous cell carcinoma (SqCC), and small-cell lung cancer (SCLC), was evaluated. A cohort of 80 ADC, 80 SqCC, 80 SCLC, and 30 skeletal muscle specimens was assembled; slides were scanned; tumor areas were annotated; image patches were extracted; and cases were randomly assigned to a training, validation or test set. Multiple CNN architectures (VGG16, InceptionV3, and InceptionResNetV2) were trained and optimized to classify the four entities. A quality control (QC) metric was established. An optimized InceptionV3 CNN architecture yielded the highest classification accuracy and was used for the classification of the test set. Image patch and patient-based CNN classification results were 95% and 100% in the test set after the application of strict QC. Misclassified cases mainly included ADC and SqCC. The QC metric identified cases that needed further IHC for definite entity subtyping. The study highlights the potential and limitations of CNN image classification models for tumor differentiation.https://www.mdpi.com/2072-6694/12/6/1604Artificial intelligencedeep learninglung cancerhistologynon-small cell lung cancersmall cell lung cancer